In vitro uptake and release of natamycin Dex-b-PLA nanoparticles from model contact lens materials

References

• Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull. World Health Organ. 2001;79:214–221.
   PubMed Web of Science ®Google Scholar
• Thomas PA. Current perspectives on ophthalmic mycoses. Clin. Microbiol. Rev. 2003;16:730–797.
   PubMed Web of Science ®Google Scholar
• Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis: a three-year study. Indian J. Ophthalmol. 2003;51:315–321.
   PubMedGoogle Scholar
• Leck A, Thomas P, Hagan M, Kaliamurthy J, Ackuaku E, John M, Newman M, Codjoe F, Opintan J, Kalavathy C. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br. J. Ophthalmol. 2002;86:1211–1215.
   PubMed Web of Science ®Google Scholar
• Bharathi MJ, Ramakrishnan R, Shivakumar C, Meenakshi R, Lionalraj D. Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J. Ophthalmol. 2010;58:497–507.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Das D, Mondal KK, Ghanta AK, Purkrit SK, Bhasrar R. Epidemiology and laboratory diagnosis of fungal corneal ulcer in the Sundarban Region of West Bengal, eastern India. Nepal J. Ophthalmol. 2012;4:29–36.
   PubMedGoogle Scholar
• Katiyar R, Deorukhkar S, Saini S. Epidemiological features and laboratory results of bacterial and fungal keratitis: a five-year study at a rural tertiary-care hospital in western Maharashtra, India. Singapore Med. J. 2012;53:264–267.
   PubMedGoogle Scholar
• Xuguang S, Zhixin W, Zhiqun W, Shiyun L, Ran L. Ocular fungal isolates and antifungal susceptibility in northern China. Am. J. Ophthalmol. 2007;143:131–133.
   PubMed Web of Science ®Google Scholar
• Sun XG, Zhang Y, Li R, Wang ZQ, Luo SY, Jin XY, Zhang WH. Etiological analysis on ocular fungal infection in the period of 1989–2000. Chin. Med. J. (Engl). 2004;117:598–600.
   PubMed Web of Science ®Google Scholar
• Asbell P, Stenson S. Ulcerative keratitis: survey of 30 years’ laboratory experience. Arch. Ophthalmol. 1982;100:77–80.
   PubMedGoogle Scholar
• FlorCruz NV, Peczon IV, Evans JR. Medical interventions for fungal keratitis. Cochrane Database Syst. Rev. 2012;2:CD004241.
   Google Scholar
• Luisa HL. Therapeutic contact lens-related bilateral fungal keratitis. Eye Contact Lens. 2002;28:149–150.
   Google Scholar
• Choi DM, Goldstein MH, Salierno A, Driebe WT. Fungal keratitis in a daily disposable soft contact lens wearer. Eye Contact Lens. 2001;27:111–112.
   Google Scholar
• Le Liboux M, Ibara S, Quinio D, Moalic E. Fungal keratitis in a daily disposable soft contact lens wearer. J. Français D’ophtalmologie. 2004;27:401–403.
   PubMedGoogle Scholar
• Elder BL, Bullock JD, Warwar RE, Khamis HJ, Khalaf SZ. Pan-antimicrobial failure of alexidine as a contact lens disinfectant when heated in Bausch & Lomb plastic containers: implications for the worldwide Fusarium keratitis epidemic of 2004 to 2006. Eye Contact Lens. 2012;38:222–226.
   PubMedGoogle Scholar
• Yildiz EH, Abdalla YF, Elsahn AF, Rapuano CJ, Hammersmith KM, Laibson PR, Cohen EJ. Update on fungal keratitis from 1999 to 2008. Cornea. 2010;29:1406–1411.
   PubMed Web of Science ®Google Scholar
• Bullock JD, Elder BL, Khamis HJ, Warwar RE. Effects of time, temperature, and storage container on the growth of Fusarium species: implications for the worldwide Fusarium keratitis epidemic of 2004–2006. Arch. Ophthalmol. 2011;129:133–136.
   PubMed Web of Science ®Google Scholar
• O’Day DM. Selection of appropriate antifungal therapy. Cornea. 1987;6:238–245.
   PubMed Web of Science ®Google Scholar
• Loh AR, Hong K, Lee S, Mannis M, Acharya NR. Practice patterns in the management of fungal corneal ulcers. Cornea. 2009;28:856–859.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Rana C, Singh H. Development of effective ocular preparations of antifungal agents. J. Ocul. Pharmacol. 2008;24:481–494.
   Google Scholar
• Le Bourlais C, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems–recent advances. Prog. Retin. Eye Res. 1998;17:33–58.
   PubMed Web of Science ®Google Scholar
• Yolton DP. Anti infective drugs. In: Bartlett JD, Jaanus SD, editors. Clinical ocular pharmacology. Woburn, MA: Butterworth-Heineman; 2001. p. 219–264.
   Google Scholar
• Lim L, Tan D, Chan WK. Therapeutic use of Bausch & Lomb PureVision contact lenses. CLAO J. 2001;27:179–185.
   PubMedGoogle Scholar
• Arora R, Jain S, Monga S, Narayanan R, Raina UK, Mehta DK. Efficacy of continuous wear PureVision contact lenses for therapeutic use. Cont. Lens Anterior Eye. 2004;27:39–43.
   PubMedGoogle Scholar
• Foulks G, Harvey T, Raj C. Therapeutic contact lenses: the role of high-Dk lenses. Ophthalmol. Clin. North Am. 2003;16:455–461.
   PubMedGoogle Scholar
• Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. Invest. Ophthalmol. Vis. Sci. 2004;45:2342–2347.
   PubMed Web of Science ®Google Scholar
• Phan CM, Subbaraman LN. In vitro uptake and release kinetics of natamycin from conventional and silicone hydrogel contact lens materials. Eye Contact Lens. 2012;39:162–168.
   Google Scholar
• Gaudana R, Jwala J, Boddu SHS, Mitra AK. Recent perspectives in ocular drug delivery. Pharm. Res. 2009;26:1197–1216.
   PubMed Web of Science ®Google Scholar
• Budai L, Hajdú M, Budai M, Gróf P, Béni S, Noszál B, Klebovich I, Antal I. Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations. Int. J. Pharm. 2007;343:34–40.
   PubMed Web of Science ®Google Scholar
• Li C-C, Abrahamson M, Kapoor Y, Chauhan A. Timolol transport from microemulsions trapped in HEMA gels. J. Colloid Interface Sci. 2007;315:297–306.
   PubMed Web of Science ®Google Scholar
• Kassem M, Abdel Rahman A, Ghorab M, Ahmed M, Khalil R. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int. J. Pharm. 2007;340:126–133.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov. Today. 2008;13:144–151.
   PubMed Web of Science ®Google Scholar
• Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Sci. Am. 1994;263:1600–1603.
   Google Scholar
• Gaucher G, Marchessault RH, Leroux JC. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J. Controlled Release. 2010;143:2–12.
   PubMed Web of Science ®Google Scholar
• Karnik R, Gu F, Basto P, Cannizzaro C, Dean L, Kyei-Manu W, Langer R, Farokhzad OC. Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett. 2008;8:2906–2912.
   PubMed Web of Science ®Google Scholar
• Snyder C. A primer on contact lens materials. Contact Lens Spectr. 2004;19:34–39.
   Google Scholar
• Green JA, Phillips KS, Hitchins VM, Lucas AD, Shoff ME, Hutter JC, Rorer EM, Eydelman MB. Material properties that predict preservative uptake for silicone hydrogel contact lenses. Eye Contact Lens. 2012;38:350–357.
   PubMed Web of Science ®Google Scholar
• Verma MS, Liu S-Y, Chen YY, Meerasa A, Gu FX. Size-tunable nanoparticles composed of dextran-b-poly(D,L-lactide) for drug delivery applications. Nano Res. 2012;5:49–61.
   Web of Science ®Google Scholar
• Kim SW, Bae YH, Okano T. Hydrogels: swelling, drug loading, and release. Pharm. Res. 1992;9:283–290.
   PubMed Web of Science ®Google Scholar
• Ciolino JB, Hudson SP, Mobbs AN, Hoare TR, Iwata NG, Fink GR, Kohane DS. A prototype antifungal contact lens. Invest. Ophthalmol. Vis. Sci. 2011;52:6286–6291.
   PubMed Web of Science ®Google Scholar
• Dekker J, Ark P. Protection of antibiotic pimaricin from oxidation and ultraviolet light by chlorophyllin and other compounds. Antibiot. Chemother. 1959;9:327–332.
   Google Scholar
• Koontz JL, Marcy JE, Barbeau WE, Duncan SE. Stability of natamycin and its cyclodextrin inclusion complexes in aqueous solution. J. Agric. Food Chem. 2003;51:7111–7114.
   PubMed Web of Science ®Google Scholar
• van Beek M, Weeks A, Jones L, Sheardown H. Immobilized hyaluronic acid containing model silicone hydrogels reduce protein adsorption. J. Biomater. Sci., Polym. Ed. 2008;19:1425–1436.
   PubMed Web of Science ®Google Scholar
• Kim J, Conway A, Chauhan A. Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses. Biomaterials. 2008;29:2259–2269.
   PubMed Web of Science ®Google Scholar
• Xu J, Li X, Sun F, Cao P. PVA hydrogels containing β-cyclodextrin for enhanced loading and sustained release of ocular therapeutics. J. Biomater. Sci., Polym. Ed. 2010;21:1023–1038.
   PubMed Web of Science ®Google Scholar
• Karlgard C, Wong N, Jones L, Moresoli C. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int. J. Pharm. 2003;257:141–151.
   PubMed Web of Science ®Google Scholar
• Peng CC, Kim J, Chauhan A. Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers. Biomaterials. 2010;31:4032–4047.
   PubMed Web of Science ®Google Scholar
• Brazel CS, Peppas NA. Modeling of drug release from swellable polymers. Eur. J. Pharm. Biopharm. 2000;49:47–58.
   PubMed Web of Science ®Google Scholar
• Chrai SS, Makoid MC, Eriksen SP, Robinson JR. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. J. Pharm. Sci. 1974;63:333–338.
   PubMed Web of Science ®Google Scholar
• Friedlaender MH, Breshears D, Amoozgar B, Sheardown H, Senchyna M. The dilution of benzalkonium chloride (BAK) in the tear film. Adv. Ther. 2006;23:835–841.
   PubMed Web of Science ®Google Scholar
• Shell JW. Pharmacokinetics of topically applied ophthalmic drugs. Surv. Ophthalmol. 1982;26:207–218.
   PubMed Web of Science ®Google Scholar
• Ghate D, Edelhauser HF. Barriers to glaucoma drug delivery. J. Glaucoma. 2008;17:147–156.
   PubMed Web of Science ®Google Scholar
• Le Bourlais C, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems – recent advances. Prog. Retin. Eye Res. 1998;17:33–58.
   PubMed Web of Science ®Google Scholar
• Paugh JR, Stapleton F, Keay L, Ho A. Tear exchange under hydrogel contact lenses: methodological considerations. Invest. Ophthalmol. Vis. Sci. 2001;42:2813–2820.
   PubMed Web of Science ®Google Scholar
• Lin MC, Soliman GN, Lim VA, Giese ML, Wofford LE, Marmo C, Radke C, Polse KA. Scalloped channels enhance tear mixing under hydrogel contact lenses. Optom. Vis. Sci. 2006;83:874–878.
   PubMed Web of Science ®Google Scholar
• Hehl EM, Beck R, Luthard K, Guthoff R, Drewelow B. Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses. Eur. J. Clin. Pharmacol. 1999;55:317–323.
   PubMed Web of Science ®Google Scholar
• Haller I, Plempel M. Experimental in vitro and in vivo comparison of modern antimycotics. Curr. Med. Res. Opin. 1977;5:315–327.
   PubMedGoogle Scholar
• Xu Y, Pang G, Gao C, Zhao D, Zhou L, Sun S, Wang B. In vitro comparison of the efficacies of natamycin and silver nitrate against ocular fungi. Antimicrob. Agents Chemother. 2009;53:1636–1638.
   PubMedGoogle Scholar